Body under Siege: Inflammation and Autoimmunity

October 29 - November 1, 2009
The Wild Horse Pass Resort
Chandler (Phoenix), Arizona

Bonus Electives:

LDA Immunotherapy - Ultra Low Dose Enzyme Activated Immunotherapy (formerly known as EPD)

LDA (short for "low dose allergens", or ultra low dose enzyme activated immunotherapy) is a method of immunotherapy enhanced by a minute dose of the enzyme, beta glucuronidase (dose is 10-13). The beta glucuronidase activates extremely miniscule doses of various allergens (10-6 to 10-17) and stimulates the production of T-suppressor cells. These cells actively "switch off" helper cells that are erroneously causing patients to be ill by misidentifying normal substances in the body to be allergens. T-cells may live for long periods of time in the bloodstream, so LDA needs to be administered only every 2 months at first, and then less often as time passes, generally with one to three tiny (1/20 c.c.) intradermal (in the first layer of skin) injections on the inner aspect of the forearm.

LDA is used to treat all types of allergy, sensitivity and intolerance to inhalants (pollens, dust, mites, danders, etc.), foods and chemicals. It is used to treat such conditions as seasonal and perennial hay fever, asthma, all types of food allergy and many other problems. It is also used to treat autoimmune diseases such as rheumatoid arthritis and ankylosing spondylitis. Since LDA uses mixtures for treatment, testing is usually not required.

SCHEDULE

The American Academy of Environmental Medicine designates this educational activity for a maximum of 3.0 AMA PRA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Prolotherapy Workshop for Physicians
This comprehensive one-day program will train participants in Prolotherapy also referred to as sclerosant therapy, sclerotherapy, regenerative injection therapy, 'proliferative' injection therapy and nonsurgical ligament reconstruction.. The morning session includes a didactic portion, where the participants will learn how to perform this procedure. The afternoon session consists of extensive hands-on training used to cement the didactic portion of the course, so that participants leave with a comprehensive understanding of Prolotherapy. This allows the participants to implement this procedure into their practice as soon as they feel comfortable. This course will pay for itself in your first day of practice.

SCHEDULE

The American Academy of Environmental Medicine designates this educational activity for a maximum of 6.5 AMA PRA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

( Top )